New Intel chip has possible device uses; TherOx advances oxygen device IDE study;

@FierceMedDev: Popular yesterday: Intuitive's surgical robots slammed in another study. Article | Follow @FierceMedDev

@DamianFierce: Dako got an FDA warning letter at the plant where it makes its Herceptin companion diagnostic. News | Follow @DamianFierce

@MarkHFierce: Baxter snatched up a tiny startup after closing a nearly $4B deal for Gambro. ICYMI yesterday | Follow @MarkHFierce

> Intel is launching a new line of processors, called Quark, that are designed, in part, for wearable medical devices. Story

> Syneron Medical ($ELOS) won FDA clearance and a CE mark for its new non-invasive body shaping tech. Item

> TherOx said it's completed enrollment in an IDE pilot study of a next-generation oxygen therapy device that helps salvage heart muscle after an attack. Item 

> Sweden's Aerocrine is launching its new portable, hand-held point-of-care device to measure inflamed airways. Item

> Fluke Biomedical, which provides medical device test and safety equipment, is launching its first iPad application. Item

> Colonoscopy device developer Invendo Medical has named a new COO and CTO, respectively; they cut their teeth at companies including Johnson & Johnson ($JNJ) and B. Braun. Item

> A scientist at Saudi Arabia's King Saud University has developed a device that helps surgeons determine the source of brain hemorrhaging. Story

@FierceBiotech: ICYMI yesterday: Is there a major R&D overhaul coming at Merck, or just more streamlining? Article | Follow @FierceBiotech

@JohnCFierce: ICYMI: FDA experts endorse new COPD blockbuster from GlaxoSmithKline, Theravance. Story | Follow @JohnCFierce

@EmilyMFierce: This week's issue of FierceBiotech Research: Parkinson's research gets boost; Drug combo tackles coronavirus. Check it out | Follow @EmilyMFierce

@Ry_McBride: Citivas scoops up $38M B round for inhaled Parkinsons drug. News | Follow @Ry_McBride

> OvaScience shares blitzed after FDA steps in to supervise lead product. News

> Merck laterals cancer drug to hungry AstraZeneca, focuses on star programs. Article

> Chimerix reports PhII failure for lead antiviral. Item

Pharma News

@FiercePharma: Italy's Recordati set to buy Spain's Laboratorios Casen Fleet for $122.4M. ICYMI yesterday | Follow @FiercePharma

@EricPFierce: KKR looks to buy stake in Gland Pharma as emotions are running high in India over loss of domestic cos. Report | Follow @EricPFierce

@CarlyHFierce: On why silence from Vivus is not golden. More via Seeking Alpha | Follow @CarlyHFierce

> South Africa writes IP policy making it harder to get drug patents. Story

> FDA ratchets up requirements on long-acting, extended-release opioids. Article

Drug Delivery News

@MichaelGFierce: Nanodiamonds deliver brain cancer drugs safely, UCLA team shows. Report | Follow @MichaelGFierce

> Activaero, Chiesi team up for cystic fibrosis drug-device research. News

> Low-cost microspheres take short-lived cancer drugs to brain. Article

> Oramed wins Chinese patent for oral core technology. Item

> CeQur closes $27M round to fund insulin delivery device. Story

Diagnostics News

> Nuclea snatches up Wilex AG Dx subsidiary. Story

> T2 jumps into pivotal trial for Candida assay. News

> NanoString gains FDA blessing for in vitro breast cancer assay. Report

> FDA cites Dx maker Dako for quality system violations. Article

> Study: Abbott blood test spots more female heart attack risks. Item

Suggested Articles

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.

Insulet announced new agreements with Abbott and Dexcom to connect their continuous glucose monitors with its upcoming tubeless, digital insulin pump,

In an SEC filing, Baxter International disclosed that it may have overstated its income over multiple years, inflating it by about $276 million.